Volumes below this such as 0.05mL or 0.03mL introduce significant dose variance because the syringe markings are spaced too far apart for precise measurement
Unlike a typical FDA panel, several members make their living prescribing, researching, or selling peptide therapies, raising questions about how the debate will unfold
[DOI] [PubMed] [Google Scholar] 86.Jendle J., Nauck M.A., Matthews D.R., Frid A., Hermansen K., Dring M., Zdravkovic M., Strauss B.J., Garber A.J., LEAD-2 and LEAD-3 Study Groups Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
(PubMed) Rebouche CJ, Lombard KA, Chenard CA
(2015), Nutrition & Metabolism, 12, 48